Committed to Excellence in Cancer Research, Education and Patient Care
Inroads
August 2019
Tulane Lakeside Hospital Now Offering
3D Breast Biopsy
The Hologic® Affirm™ Prone Breast Biopsy System uses 3D imaging for biopsy guidance and increased precision.
Tulane Lakeside Hospital is one of the first facilities in the region to offer 3D-guided breast biopsy, an advanced, minimally invasive technique that provides a sample of tissue that doctors use to identify and diagnose breast abnormalities. 
 
The Hologic® Affirm™ Prone Breast Biopsy System uses 3D imaging for biopsy guidance and increased precision. The 3D visualization facilitates the localization and accurate targeting of lesions, including those that can be challenging to detect with conventional imaging techniques.
 
In addition, this new biopsy technology has several key advantages over standard X-ray biopsy procedures, including faster targeting and fewer X-ray exposures, resulting in shorter procedure times and reduced patient radiation doses. The new biopsy system also has the advantage of allowing the patient to recline comfortably in the prone position, removed from the field of view of the biopsy instruments.
 
“Tulane Lakeside Hospital is pleased to offer this advanced technology to the women in our community,” said Tara Beth Anderson, associate chief nursing officer at Tulane Lakeside. “The ability to biopsy small areas of interest that may not be visible using other imaging techniques provides a significant advantage to our physicians and their patients. And integrating this ability into a system that allows procedures to be performed with patients in the prone position represents a transformative innovation in breast biopsy. Tulane’s investment in this technology is another affirmation of our commitment to the early detection and diagnosis of this devastating disease.”
 
Tulane Health System has a tradition of investing in the latest technology to detect breast cancer. Tulane was the first facility in the Gulf South region to offer 3D mammography, also known as breast tomosynthesis, and recently upgraded equipment to the latest Genius™ 3D Mammography™ system to provide better, earlier breast cancer detection for patients. Studies show that the 3D mammography exam has greater accuracy than 2D mammography for women across a variety of ages and breast densities. It is the only mammogram that is FDA approved as superior for women with dense breasts compared to 2D alone.
 
3D mammography is available at Tulane Medical Center and Tulane Lakeside Hospital in Metairie, and 3D breast biopsy is available at Tulane Lakeside Hospital.
 
To learn more, or to take a free breast cancer risk assessment, please visit TulaneLakeside.com .
16 Tulane Cancer Center Faculty Named
"Top Docs" by New Orleans Magazine
Hana Safah, MD, head of Tulane Cancer Center's Stem Cell Transplant Program, was named by New Orleans Magazine as a "Top Doctor" in Hematology/Medical Oncology.
New Orleans Magazine’s annual “Top Doctors” issue named 16 Tulane Cancer Center faculty as tops in their respective fields, including six who were among the area’s best hematology/medical oncology specialists:  
 
Bridgette Collins-Burow, MD, PhD
Marc J. Kahn, MD, MBA
Cindy Leissinger, MD
Nakhle Saba, MD
Hana Safah, MD
Oliver Sartor, MD

New Orleans Magazine utilized the services of Best Doctors, Inc., to compile this year’s list of 633 top local physicians in 73 specialties. 
    
Best Doctors assembles the list by contacting each doctor on the previous year’s list and asking the same question— If you or a loved one needed a doctor in your specialty, to whom would you refer them?
Doctors do not pay to be included on the list, and they are never automatically re-included.   Former “Best Doctors” are re-evaluated in each poll, along with new nominees. Doctors are allowed to vote on others in their hospital and medical practices; the feeling is that those doctors know their peers best. All voting is strictly confidential, and Best Doctors staff conduct additional research on credentials, disciplinary actions and clinical activity before a doctor is selected for the list.


Other Tulane Cancer Center faculty members making the list include: 
 
Hans Andersson MD—Medical/Pediatric Genetics & Pediatric Metabolic Diseases
Vecihi Batuman MD—Nephrology
Erin Boh MD, PhD—Dermatology
Stacy Drury MD, PhD—Child & Adolescent Psychiatry
Samir El-Dahr MD—Pediatric Nephrology
Paul L. Friedlander MD—Otolaryngology & Surgery
L. Lee Hamm MD—Nephrology
Joseph Lasky MD—Pulmonary Medicine
Raju Thomas MD, MHA—Urology
Ihor Yosypiv MD—Pediatric Nephrology
GET INTO GEAR TO SUPPORT
PROSTATE CANCER RESEARCH!

  • Proceeds benefit Dr. Oliver Sartor's Prostate Cancer Research Program.

  • One lucky winner will receive the grand prize - a GMC Canyon Pickup.

  • Raffle tickets are $100 each and a maximum of 500 will be sold.

  • Tickets can be purchased via credit card only at


  • The winner will be selected in a random drawing on November 16 and need not be present to win.

  • Good luck and thanks for your support!
Calendar of Events

benefiting Tulane Cancer Center's Prostate Cancer Research Fund

Thursday, October 3, 2019
Renaissance Hotel Grand Ballroom
Baton Rouge

benefiting Tulane Cancer Center's
Prostate Cancer Research Fund

Saturday, March 7, 2020
Stella Plantation
Braithwaite, LA

Tulane offers free prostate screenings - a PSA blood test - on the second Tuesday of each month at Tulane Comprehensive Cancer Clinic, 150 S. Liberty St., New Orleans. To make an appointment, call 504-988-6300 or 1-800-588-5800.
Quick Links